Bio-Rad Laboratories (BIO.B) vs Lumexa Imaging (LMRI)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 10, 2026.
Summary
Bio-Rad Laboratories is the larger company by market cap ($9.76 billion vs $1.01 billion), about 9.6 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BIO.B | LMRI |
|---|---|---|
| Share price | $365.08 | $10.54 |
| Market cap | $9.76B | $1.01B |
| 1-day change | 0.00% | +2.03% |
| YTD return | +17.50% | -43.03% |
| 1-year return | +28.15% | — |
| 5-year return | -50.54% | — |
| P/E ratio (TTM) | 46.27 | — |
| Forward P/E | — | 11.84 |
| EPS (TTM) | $7.89 | $-0.37 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $2.58B | — |
| Revenue growth (YoY) | +0.65% | — |
| Net income (latest FY) | $759.90M | — |
| Gross margin | 51.87% | — |
| Operating margin | 1.83% | — |
| Net margin | 29.42% | — |
| 52-week high | $365.08 | $19.45 |
| 52-week low | $244.54 | $6.45 |
| Distance from 52-week high | 0.00% | -45.81% |
| Analyst consensus | — | strong_buy |
| Avg. price target upside | — | +67.65% |
| Average volume | 4 | 430.76K |
| Shares outstanding | 5.06M | 96.07M |
| Employees | 7,450 | 5,000 |
| Sector | Healthcare | Health Care |
| Industry | Medical Devices | Medical Specialities |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Bio-Rad Laboratories is about 9.6 times larger than Lumexa Imaging by market value ($9.76B vs $1.01B).
- The two companies sit in different sectors: Bio-Rad Laboratories in Healthcare and Lumexa Imaging in Health Care.
About Bio-Rad Laboratories
BIO.B stock →Bio-Rad Laboratories, Inc. develops, manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, Latin America, and internationally.
Healthcare · Medical Devices · 7,450 employees
About Lumexa Imaging
LMRI stock →Lumexa Imaging Holdings, Inc. owns and operates diagnostic imaging centres in the United States.
Health Care · Medical Specialities · 5,000 employees
BIO.B vs LMRI FAQ
Which is bigger, Bio-Rad Laboratories or Lumexa Imaging?
Bio-Rad Laboratories (BIO.B) is larger, with a market capitalization of $9.76B compared with $1.01B for Lumexa Imaging (LMRI).
Are Bio-Rad Laboratories and Lumexa Imaging in the same industry?
No. Bio-Rad Laboratories is in the Healthcare sector, while Lumexa Imaging is in Health Care.